Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DePuy Synthes
Corin has transformed from a niche UK hip resurfacing company into an innovative global player in orthopedics with a portfolio that includes robotics. UK managing director Paul Gibbons explained the group’s approach to business during COVID-19, and its culture of innovation.
Bristol makes its own deal with Celgene ally Dragonfly, while Gilead ends virology partnerships with Durect and Precision BioSciences.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive